Table 2.
Intragroup comparison of clinical parameters and sclerostin levels in the control group at baseline and 3 months
| Control | Mean±SD | T | P |
|---|---|---|---|
| GI | |||
| Baseline | 1.2833±0.50768 | 5.196 | 0.000 (HS) |
| 3rd month | 0.5333±0.35187 | ||
| BI | |||
| Baseline | 3.4000±0.63246 | 4.516 | 0.000 (HS) |
| 3rd month | 2.5333±0.74322 | ||
| PPD (in mm) | |||
| Baseline | 5.13±0.352 | 10.458 | 0.000 (HS) |
| 3rd month | 3.47±0.640 | ||
| CAL (in mm) | |||
| Baseline | 5.33±0.488 | 7.906 | 0.000 (HS) |
| 3rd month | 3.67±0.724 | ||
| SOST (in pg/ml) | |||
| Baseline | 146.4667±49.78506 | 2.266 | 0.040 (S) |
| 3rd month | 140±41.930 |
P<0.05. HS: Highly significant; S: Significant; SD: Standard deviation; CAL: Clinical attachment level; GI: Gingival index; BI: Bleeding index; PPD: Probing pocket depth; SOST: Sclerostin